PlumX Metrics
Embed PlumX Metrics

The piriformis syndrome—a special indication for botulinum toxin

Nervenarzt, ISSN: 1433-0407, Vol: 91, Issue: 2, Page: 99-106
2020
  • 3
    Citations
  • 0
    Usage
  • 17
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

The piriformis syndrome (PiS) is a possible cause of gluteal pain radiating into the legs. From a pathophysiological anatomical point of view a division into primary and secondary PiS is made. A primary PiS is based on variants of the course of the sciatic nerve with respect to the piriformis muscle. A secondary PiS occurs as a result of hypertrophy, tension and hardening of the piriformis muscle. Muscular hypertrophy causes an impingement syndrome with pressure on the sciatic nerve in the infrapiriform foramen more often than course variants. A tentative diagnosis of PiS can be made based on anamnestic information, clinical signs of strain and the flexion adduction internal rotation (FAIR) test. If asymmetry or hypertrophy exists, the tentative diagnosis is substantiated with the representation of the piriformis muscle in computed tomography (CT). Thus, a CT-supported botulinum injection (BTX) into the piriformis muscle is indicated. This is a pathogenetic treatment approach leading to a reduction in volume. In most cases a single treatment is sufficient. Since there are no adverse consequences, the BTX into the piriformis muscle is also justified from a diagnostic and therapeutic point of view in cases of primary PiS if the clinical indications are clear and other causes can be ruled out. In an in-house case series the tentative diagnosis of PiS could be made for 19 patients and the effectiveness of BTX was confirmed.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know